Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition
Dear Colleagues! We are glad to present the 8th Edition of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation. The Standards are updated on the regular basis to incorporate...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8f928b3d4b7a4751929dcd21d8107a67 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8f928b3d4b7a4751929dcd21d8107a67 |
|---|---|
| record_format |
dspace |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetes mellitus guidelines diagnosis prevention treatment algoritms standards Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetes mellitus guidelines diagnosis prevention treatment algoritms standards Nutritional diseases. Deficiency diseases RC620-627 Ivan I. Dedov Marina V. Shestakova Aleksandr Y. Mayorov Olga K. Vikulova Gagik R. Galstyan Tamara L Kuraeva Valentina A. Peterkova Olga M Smirnova Elena G. Starostina Elena V. Surkova Olga Y. Sukhareva Alla Y. Tokmakova Minara S. Shamkhalova Ivona Renata Jarek-Martynova Diana D. Beshlieva Olga N. Bondarenko Natalya N. Volevodz Olga R. Grigoryan Roza M. Esayan Liudmila I. Ibragimova Viktor Y. Kalashnikov Dmitry V. Lipatov Ekaterina A. Shestakova Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| description |
Dear Colleagues!
We are glad to present the 8th Edition of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation.
The Standards are updated on the regular basis to incorporate new data and relevant recommendations from national and international clinical societies, including World Health Organization Guidelines (WHO, 2011, 2013), International Diabetes Federation (IDF, 2011, 2012, 2013), American Diabetes Association (ADA, 2012, 2017), American Association of Clinical Endocrinologists (AACE, 2017), International Society for Pediatric and Adolescent Diabetes (ISPAD, 2014) and Russian Association of Endocrinologists (RAE, 2011, 2012, 2015). Current edition of the “Standards” also integrates results of completed randomized clinical trials (ADVANCE, ACCORD, VADT, UKPDS, SAVOR, TECOS, LEADER, EMPA-REG OUTCOME, etc.), as well as findings from the national studies of diabetes mellitus (DM), conducted in close partnership with a number of Russian hospitals.
Latest data indicates that prevalence of DM in the world increased during the last decade more than two-fold, reaching some 415 million patients by the end of 2015. According to the current estimation by the International Diabetes Federation, 642 million patients will be suffering from DM by 2040. These observations resulted in the UN Resolution on Diabetes 61/225 passed on 20.12.2006, and in 2011 - UN Political Declaration, addressed to national health systems, calling for the establishment of multidisciplinary strategy in the prevention and control of non-communicable diseases, where special attention is drawn to the problem of diabetes as one of the leading causes of disability and mortality.
Like many other countries, Russian Federation experiences a sharp rise in the prevalence of DM. According to Russian Federal Diabetes Register, there are at least 4.35 million patients with DM in this country by the end of 2016 (3% of population) with 92% (4 million) – Type 2 DM, 6% (255 th) – Type 1 DM and 2% (75 th) – other types of DM. However, these results underestimates real quantity of patients, because they consider only registered cases. Results of Russian epidemiological study (NATION) confirmed that only 50% of Type 2 DM are diagnosed. So real prevalence of patients with DM in Russia is no less than 8-9 million patients (about 6% of population). This is a great long-term problem, because a lot of patients are not diagnosed, so they don’t receive any treatment ant have high risk of vascular complications.
Severe consequences of the global pandemics of DM include its vascular complications: nephropathy, retinopathy, coronary, cerebral, coronary and peripheral vascular disease. These conditions are responsible for the majority of cases of diabetes-related disability and death.
Current edition of the “Standards” emphasizes the patient-oriented approach in making decisions on therapeutic goals, such as levels of glycaemia and blood pressure. It also features updated guidelines on the management of Type 2 DM and its vascular complications, added information about bariatric surgery as a method of treatment of DM with morbide obesity.
This text represents a consensus by the absolute majority of national experts, achieved through a number of fruitful discussions held at national meetings and forums. These guidelines are intended for endocrinologists and diabetologists, primary care physicians, cardiologists and other medical professionals involved in prevention and treatment of DM.
On behalf of the Working Group |
| format |
article |
| author |
Ivan I. Dedov Marina V. Shestakova Aleksandr Y. Mayorov Olga K. Vikulova Gagik R. Galstyan Tamara L Kuraeva Valentina A. Peterkova Olga M Smirnova Elena G. Starostina Elena V. Surkova Olga Y. Sukhareva Alla Y. Tokmakova Minara S. Shamkhalova Ivona Renata Jarek-Martynova Diana D. Beshlieva Olga N. Bondarenko Natalya N. Volevodz Olga R. Grigoryan Roza M. Esayan Liudmila I. Ibragimova Viktor Y. Kalashnikov Dmitry V. Lipatov Ekaterina A. Shestakova |
| author_facet |
Ivan I. Dedov Marina V. Shestakova Aleksandr Y. Mayorov Olga K. Vikulova Gagik R. Galstyan Tamara L Kuraeva Valentina A. Peterkova Olga M Smirnova Elena G. Starostina Elena V. Surkova Olga Y. Sukhareva Alla Y. Tokmakova Minara S. Shamkhalova Ivona Renata Jarek-Martynova Diana D. Beshlieva Olga N. Bondarenko Natalya N. Volevodz Olga R. Grigoryan Roza M. Esayan Liudmila I. Ibragimova Viktor Y. Kalashnikov Dmitry V. Lipatov Ekaterina A. Shestakova |
| author_sort |
Ivan I. Dedov |
| title |
Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| title_short |
Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| title_full |
Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| title_fullStr |
Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| title_full_unstemmed |
Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition |
| title_sort |
standards of specialized diabetes care. edited by dedov ii, shestakova mv, mayorov ay. 8th edition |
| publisher |
Endocrinology Research Centre |
| publishDate |
2017 |
| url |
https://doaj.org/article/8f928b3d4b7a4751929dcd21d8107a67 |
| work_keys_str_mv |
AT ivanidedov standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT marinavshestakova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT aleksandrymayorov standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT olgakvikulova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT gagikrgalstyan standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT tamaralkuraeva standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT valentinaapeterkova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT olgamsmirnova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT elenagstarostina standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT elenavsurkova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT olgaysukhareva standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT allaytokmakova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT minarasshamkhalova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT ivonarenatajarekmartynova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT dianadbeshlieva standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT olganbondarenko standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT natalyanvolevodz standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT olgargrigoryan standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT rozamesayan standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT liudmilaiibragimova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT viktorykalashnikov standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT dmitryvlipatov standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition AT ekaterinaashestakova standardsofspecializeddiabetescareeditedbydedoviishestakovamvmayorovay8thedition |
| _version_ |
1718429544302510080 |
| spelling |
oai:doaj.org-article:8f928b3d4b7a4751929dcd21d8107a672021-11-14T09:00:21ZStandards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition2072-03512072-037810.14341/DM20171S8https://doaj.org/article/8f928b3d4b7a4751929dcd21d8107a672017-01-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8341https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Dear Colleagues! We are glad to present the 8th Edition of Standards of Diabetes Care. These evidence-based guidelines were designed to standardize and facilitate diabetes care in all regions of the Russian Federation. The Standards are updated on the regular basis to incorporate new data and relevant recommendations from national and international clinical societies, including World Health Organization Guidelines (WHO, 2011, 2013), International Diabetes Federation (IDF, 2011, 2012, 2013), American Diabetes Association (ADA, 2012, 2017), American Association of Clinical Endocrinologists (AACE, 2017), International Society for Pediatric and Adolescent Diabetes (ISPAD, 2014) and Russian Association of Endocrinologists (RAE, 2011, 2012, 2015). Current edition of the “Standards” also integrates results of completed randomized clinical trials (ADVANCE, ACCORD, VADT, UKPDS, SAVOR, TECOS, LEADER, EMPA-REG OUTCOME, etc.), as well as findings from the national studies of diabetes mellitus (DM), conducted in close partnership with a number of Russian hospitals. Latest data indicates that prevalence of DM in the world increased during the last decade more than two-fold, reaching some 415 million patients by the end of 2015. According to the current estimation by the International Diabetes Federation, 642 million patients will be suffering from DM by 2040. These observations resulted in the UN Resolution on Diabetes 61/225 passed on 20.12.2006, and in 2011 - UN Political Declaration, addressed to national health systems, calling for the establishment of multidisciplinary strategy in the prevention and control of non-communicable diseases, where special attention is drawn to the problem of diabetes as one of the leading causes of disability and mortality. Like many other countries, Russian Federation experiences a sharp rise in the prevalence of DM. According to Russian Federal Diabetes Register, there are at least 4.35 million patients with DM in this country by the end of 2016 (3% of population) with 92% (4 million) – Type 2 DM, 6% (255 th) – Type 1 DM and 2% (75 th) – other types of DM. However, these results underestimates real quantity of patients, because they consider only registered cases. Results of Russian epidemiological study (NATION) confirmed that only 50% of Type 2 DM are diagnosed. So real prevalence of patients with DM in Russia is no less than 8-9 million patients (about 6% of population). This is a great long-term problem, because a lot of patients are not diagnosed, so they don’t receive any treatment ant have high risk of vascular complications. Severe consequences of the global pandemics of DM include its vascular complications: nephropathy, retinopathy, coronary, cerebral, coronary and peripheral vascular disease. These conditions are responsible for the majority of cases of diabetes-related disability and death. Current edition of the “Standards” emphasizes the patient-oriented approach in making decisions on therapeutic goals, such as levels of glycaemia and blood pressure. It also features updated guidelines on the management of Type 2 DM and its vascular complications, added information about bariatric surgery as a method of treatment of DM with morbide obesity. This text represents a consensus by the absolute majority of national experts, achieved through a number of fruitful discussions held at national meetings and forums. These guidelines are intended for endocrinologists and diabetologists, primary care physicians, cardiologists and other medical professionals involved in prevention and treatment of DM. On behalf of the Working GroupIvan I. DedovMarina V. ShestakovaAleksandr Y. MayorovOlga K. VikulovaGagik R. GalstyanTamara L KuraevaValentina A. PeterkovaOlga M SmirnovaElena G. StarostinaElena V. SurkovaOlga Y. SukharevaAlla Y. TokmakovaMinara S. ShamkhalovaIvona Renata Jarek-MartynovaDiana D. BeshlievaOlga N. BondarenkoNatalya N. VolevodzOlga R. GrigoryanRoza M. EsayanLiudmila I. IbragimovaViktor Y. KalashnikovDmitry V. LipatovEkaterina A. ShestakovaEndocrinology Research Centrearticlediabetes mellitusguidelinesdiagnosispreventiontreatmentalgoritmsstandardsNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 1S, Pp 1-121 (2017) |